在急性髓性白血病中准细胞死亡途径:分子机制和临床影响 (综述)
Reaila Jianati1, Haijing Chen1, Xi Yang1
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300380, P.R. China.
Oncology reports
|October 17, 2025
概括
本综述探讨了急性髓性白血病 (AML) 中的细胞死亡途径,强调了针对多个途径为这种复杂的血液癌症提供了新的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 急性髓性白血病 (AML) 是一种复杂的血液癌症,具有高异质性和耐治疗性.
- 由于复杂的分子相互作用和抵抗机制,目前的疗法取得的成功有限.
- 现有的研究往往忽视了不同细胞死亡途径之间的相互作用.
研究的目的:
- 系统地审查和比较AML中关键的细胞死亡模式:自,细胞亡,细胞亡,尸亡,铁亡和cuproptosis.
- 分析这些通路的分子特征,触发因素,信号中心和代谢微环境调节.
- 探索针对这些细胞死亡途径之间的交叉声的治疗潜力,以实现协同效应的组合疗法.
主要方法:
- 系统的文献审查和整合关于AML细胞死亡途径的数据.
- 对分子机制,信号网络和代谢相互作用的比较分析.
- 基于路径交叉通话的治疗策略的讨论.
主要成果:
- 确定了关键的细胞死亡模式 (自,亡,烧亡,亡,铁亡,亡) 以及它们在AML中的作用.
- 详细介绍了每个途径在代谢微环境中的分子特征,触发因素和调节网络.
- 突出了这些多样化的细胞死亡途径之间的动态交叉和协同相互作用.
结论:
- 了解多个细胞死亡途径之间的交叉通话对于克服AML治疗耐药性和改善患者的治疗结果至关重要.
- 利用这种交叉通话为设计新的协同效应组合疗法提供了巨大的潜力.
- 进一步研究AML进展中各种细胞死亡模式的过渡机制对于开发创新的治疗方法至关重要.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:30Overview of Cell Death
9.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
01:31The Intrinsic Apoptotic Pathway
8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
01:27Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
01:17The Extrinsic Apoptotic Pathway
8.1K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.1K